Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder
Clinical trial NCT00266630 · COMPLETED
Trial details
- NCT number
- NCT00266630
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2009-05-01
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.